Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec:20 Suppl 3:23-28.
doi: 10.1016/j.jcf.2021.09.004.

Barriers and facilitators to implementing telehealth services during the COVID-19 pandemic: A qualitative analysis of interviews with cystic fibrosis care team members

Aricca D Van Citters  1 , Olivia Dieni  2 , Peter Scalia  3 , Christopher Dowd  2 , Kathryn A Sabadosa  2 , Jill D Fliege  4 , Manu Jain  5 , Robert W Miller  6 , Clement L Ren  7
Affiliations

Barriers and facilitators to implementing telehealth services during the COVID-19 pandemic: A qualitative analysis of interviews with cystic fibrosis care team members

Aricca D Van Citters et al. J Cyst Fibros. 2021 Dec.

Abstract

Background: The COVID-19 pandemic forced cystic fibrosis (CF) care programs to rapidly shift from in-person care delivery to telehealth. Our objective was to provide a qualitative exploration of facilitators and barriers to: 1) implementing high-quality telehealth and 2) navigating reimbursement for telehealth services.

Methods: We used data from the 2020 State of Care CF Program Survey (n=286 U.S. care programs) administered in August-September to identify two cohorts of programs, with variation in telehealth quality (n=12 programs) and reimbursement (n=8 programs). We conducted focus groups and semi-structured interviews with CF program directors and coordinators in December 2020, approximately 9 months from onset of the pandemic. We used the Consolidated Framework for Implementation Research to identify facilitators and barriers of implementation, and inductive thematic analysis to identify facilitators and barriers of reimbursement.

Results: Factors differentiating programs with greater and lower perceived telehealth quality included telehealth characteristics (perceived advantage over in-person care, cost, platform quality); external influences (needs and resources of those served by the CF program), characteristics of the CF program (compatibility with workflows, relative priority, available resources); characteristics of team members (individual stage of change), and processes for implementation (engaging patients and teams). Reimbursement barriers included documentation to optimize billing; reimbursement of multi-disciplinary team members, remote monitoring, and telephone-only telehealth; and lower volume of patients.

Conclusions: A number of factors are associated with successful implementation and reimbursement of telehealth. Future efforts should provide guidance and incentives that support telehealth delivery and infrastructure, share best practices across CF programs, and remove barriers.

Keywords: Barriers; Cystic fibrosis; Facilitators; Implementation; Telehealth.

PubMed Disclaimer

Figures

Figure 1
Fig. 1
Presence of CFIR constructs among CF programs perceiving telehealth as similar (n=5) or worse (n=7) quality than in-person care.
See this image and copyright information in PMC

Comment in

References

    1. Compton M, Soper M, Reilly B, Gettle L, List R, Bailey M, et al. A Feasibility Study of Urgent Implementation of Cystic Fibrosis Multidisciplinary Telemedicine Clinic in the Face of COVID-19 Pandemic: Single-Center Experience. Telemed J E Health. 2020;26:978–984. doi: 10.1089/tmj.2020.0091. - DOI - PubMed
    1. Koonin LM, Hoots B, Tsang CA, Leroy Z, Farris K, Jolly BT, et al. Trends in the Use of Telehealth During the Emergence of the COVID-19 Pandemic — United States, January–March 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1595–1599. - PMC - PubMed
    1. Farfour E, Picard C, Beaumont L, Lesprit P, Ballester MC, Ackermann F, et al. COVID-19 in lung-transplanted and cystic fibrosis patients: Be careful. J Cyst Fibros. 2020;19:e16–ee7. doi: 10.1016/j.jcf.2020.03.021. - DOI - PMC - PubMed
    1. Dowd C, Van Citters AD, Dieni O, Willis A, Powell L, Sabadosa K. Design and methods for understanding the state of cystic fibrosis care amid the COVID-19 pandemic. J Cyst Fibros. 2021;20(S3):S3–S8. - PMC - PubMed
    1. List R, Compton M, Soper M, Bruschwein H, Gettle L, Bailey M, et al. Preserving Multidisciplinary Care Model and Patient Safety During Reopening of Ambulatory Cystic Fibrosis Clinic for Nonurgent Care: A Hybrid Telehealth Model. Telemed J E Health. 2021;27:193–199. doi: 10.1089/tmj.2020.0247. - DOI - PubMed

Publication types

MeSH terms